We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Anionic nanoplastic exposure induces endothelial leakiness
Summary
Researchers discovered that nanoplastics made of anionic polystyrene and poly(methyl methacrylate) can disrupt the junctions between blood vessel cells, causing increased vascular leakiness. This effect was dose-dependent and driven by biophysical interactions rather than typical cell toxicity like oxidative stress or cell death. The findings reveal a previously unknown way that nanoplastics could affect the body's circulatory system by making blood vessels more permeable.
The global-scale production of plastics has been instrumental in advancing modern society, while the rising accumulation of plastics in landfills, oceans, and anything in between has become a major stressor on environmental sustainability, climate, and, potentially, human health. While mechanical and chemical forces of man and nature can eventually break down or recycle plastics, our understanding of the biological fingerprints of plastics, especially of nanoplastics, remains poor. Here we report on a phenomenon associated with the nanoplastic forms of anionic polystyrene and poly(methyl methacrylate), where their introduction disrupted the vascular endothelial cadherin junctions in a dose-dependent manner, as revealed by confocal fluorescence microscopy, signaling pathways, molecular dynamics simulations, as well as ex vivo and in vivo assays with animal model systems. Collectively, our results implicated nanoplastics-induced vasculature permeability as primarily biophysical-biochemical in nature, uncorrelated with cytotoxic events such as reactive oxygen species production, autophagy, and apoptosis. This uncovered route of paracellular transport has opened up vast avenues for investigating the behaviour and biological effects of nanoplastics, which may offer crucial insights for guiding innovations towards a sustainable plastics industry and environmental remediation.
Sign in to start a discussion.